Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2014

Open Access 01-12-2014 | Poster presentation

PB.17. Are patients who have had total body irradiation at similar risk of breast cancer to those having mantle radiotherapy? A review of the evidence and suggestions on breast imaging surveillance

Authors: J Muscat, G Rubin

Published in: Breast Cancer Research | Special Issue 1/2014

Login to get access

Excerpt

There are an increasing number of total body irradiation (TBI) survivors. UK haematology and oncology units follow international guidelines and advise that they should have annual mammography from age 40. …
Literature
1.
Freidman DL, Rovo A, et al: Increased risk of breast cancer among survivors of allogenic hemopoetic cell transplantation. Blood. 2008, 11: P939-P944.CrossRef
Metadata
Title
PB.17. Are patients who have had total body irradiation at similar risk of breast cancer to those having mantle radiotherapy? A review of the evidence and suggestions on breast imaging surveillance
Authors
J Muscat
G Rubin
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2014
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3736

Other articles of this Special Issue 1/2014

Breast Cancer Research 1/2014 Go to the issue

Poster presentation

PB.10. Stereotactic 20 mm basket Intact Breast Lesion Excision System biopsy for indeterminate breast microcalcification: pilot study within a UK breast unit

Poster presentation

PB.28. Determination of recall rates for assessment in women undergoing annual surveillance breast MRI: is a rate <10% achievable?

Poster presentation

PB.42. Influences upon presentation to the symptomatic breast clinic: is there an increase in symptomatic referrals due to the physical presence of the breast screening van within an area?

Poster presentation

PB.45. Correlation of perilesional tissue stiffness measured by ultrasound strain elastography with breast density

Poster presentation

PB.44. Do qualitative patterns of stiffness help differentiate benign from malignant breast masses of similar stiffness during shear wave elastography?

Oral presentation

Multidetector CT Improving Surgical Outcomes in Breast Cancer (MISO BC)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits